# Oklahoma Medical Research Foundation

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/oklahoma-medical-research-foundation/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 75.2 |
| Citations | 1,440,600 |
| City | Oklahoma City |
| Country | US |
| Description | Oklahoma Medical Research Foundation is a research organisation in Oklahoma City, US. OpenAlex records 9,216 works and 1,440,600 citations for it. 1,743 researchers list it as their most recent affiliation. |
| Homepage | https://omrf.org/ |
| OpenAlex ID | https://openalex.org/I30558944 |
| Region | Oklahoma |
| Researchers | 1,743 |
| ROR ID | https://ror.org/035z6xf33 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q7082264 |
| Works | 9,216 |

## University papers

Showing 12 of 52.

- [An Integrated Genomic Analysis of Human Glioblastoma Multiforme](https://scholariq.org/papers/an-integrated-genomic-analysis-of-human-glioblastoma-multiforme/)
- [Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus](https://scholariq.org/papers/development-of-autoantibodies-before-the-clinical-onset-of-systemic-lupus/)
- [The oyster genome reveals stress adaptation and complexity of shell formation](https://scholariq.org/papers/the-oyster-genome-reveals-stress-adaptation-and-complexity-of-shell-formation/)
- [Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus](https://scholariq.org/papers/interferon-inducible-gene-expression-signature-in-peripheral-blood-cells-of/)
- [A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus](https://scholariq.org/papers/a-phase-iii-randomized-placebo-controlled-study-of-belimumab-a-monoclonal/)
- [Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome](https://scholariq.org/papers/neutrophil-extracellular-traps-contribute-to-immunothrombosis-in-covid-19-acute/)
- [American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis](https://scholariq.org/papers/american-college-of-rheumatology-guidelines-for-screening-treatment-and/)
- [Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial](https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-moderately-to-severely-active-systemic-lupus/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-or-intravenous-cyclophosphamide-for-lupus-nephritis/)
- [Rapid cloning of high-affinity human monoclonal antibodies against influenza virus](https://scholariq.org/papers/rapid-cloning-of-high-affinity-human-monoclonal-antibodies-against-influenza/)
- [Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus](https://scholariq.org/papers/anifrolumab-an-anti-interferon-receptor-monoclonal-antibody-in-moderate-to/)

## University researchers

- [Joan T. Merrill](https://scholariq.org/researchers/joan-t-merrill/)
- [Judith A. James](https://scholariq.org/researchers/judith-a-james/)
- [Eliza F. Chakravarty](https://scholariq.org/researchers/eliza-f-chakravarty/)

## University top topics

Showing 8 of 25.

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cell Adhesion Molecules Research](https://scholariq.org/topics/cell-adhesion-molecules-research/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Mitochondrial Function and Pathology](https://scholariq.org/topics/mitochondrial-function-and-pathology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.